IAVI Starts First-in-Human Phase I Clinical Trial of Single-Dose Sudan Virus Vaccine Candidate

IAVI announced that the first participants have been vaccinated with a Sudan virus (SUDV) vaccine candidate in a first-in-human Phase I clinical trial in the US. The IAVI-sponsored trial was funded by the Biomedical Advanced Research and Development Authority.